Key result
AMI without ischemic pain is linked to higher mortality, driven by delayed care and complications.
Why the study?
The authors sought to describe the characteristics and outcomes of patients presenting with versus without ischemic pain among those diagnosed with acute MI.
Does presentation without ischemic pain affect 28-day case fatality in patients with acute myocardial infarction?
Cohort (n=1,711)
Yes
Does presentation without ischemic pain affect 28-day case fatality in patients with acute myocardial infarction?
Higher 28-day mortality in acute MI patients presenting without ischemic pain is driven by treatment delays and in-hospital complications rather than inherent demographic or comorbidity differences.
Heightened vigilance is needed to minimize fatal triage delays in atypical MI presentations; leaves open.
Background: Our objective was to describe characteristics of patients presenting with and without ischemic pain among those diagnosed with acute myocardial infarction (MI) using individual-level data from the Atherosclerosis Risk in Communities Study from 2005 to 2019. Methods: Acute MI included events deemed definite or probable MI by a physician panel based on ischemic pain, cardiac biomarkers, and ECG evidence. Patient characteristics included age at hospitalization, sex, race/ethnicity, comorbidities (smoking status, diabetes, hypertension, history of previous stroke, MI, or cardiovascular procedure, and history of valvular disease or cardiomyopathy) and in-hospital complications occurring during the event of interest (pulmonary edema, pulmonary embolism, in-hospital stroke, pneumonia, cardiogenic shock, ventricular fibrillation). Analyses were stratified by MI subtype (STEMI, NSTEMI, Unclassified) and patient characteristics and 28-day case fatality was compared between MI presenting with or without ischemic pain. Results: Between 2005 and 2019, there were 1711 hospitalized definite/probable MI events (47 % female, 26 % black, and age of 78 [6.7 years]). A smaller proportion of STEMI patients presented without ischemic pain compared to NSTEMI patients (20 % vs 32 %). Race, sex, age, and comorbidity profiles did not differ significantly across ischemic pain presentations. Patients presenting without ischemic pain had a higher 28-day all-cause case fatality after adjusting for age, race, sex, and comorbidities. However, after further adjustment, time from symptom onset to hospital arrival, time to treatment, and in-hospital complications explained the difference in 28-day case fatality between ischemic pain presentations. Conclusions: Future research should focus on differences in treatment delay across ischemic pain presentations rather than sex differences in acute coronary syndrome presentation.
No takes yet. Share an insight, caveat, or question.
DeBarmore et al. (2022) conducted a cohort in Acute myocardial infarction (n=1,711). Presentation without ischemic pain vs. Presentation with ischemic pain was evaluated on 28-day all-cause case fatality. Presentation without ischemic pain in acute myocardial infarction was associated with higher 28-day case fatality, which was fully explained by delays in hospital arrival, treatment, and in-hospital complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: